BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Atlanta Biotech MedShape Solutions, Inc. Raising $8 Million


7/5/2012 8:13:22 AM

MedShape Inc., which has developed a shape-shifting material to aid orthopedic surgeries, is seeking $8 million, according to a Securities and Exchange Commission filing.

The Atlanta-based biotech has raised about $2.5 million of the $8 million, the SEC filing noted.

MedShape CEO Kurt Jacobus was not available for comment.

MedShape has developed a shape-changing biopolymer material that is ideal for creating medical devices used to repair damaged ligaments, tendons and cartilage. In one variation of the technology, surgeons drill a hole into the bone and insert the polymer implants, which change shape to anchor the ruptured soft tissue back to bone.

MedShape, which serves the shoulder, and foot and ankle surgery markets, has received Food and Drug Administration clearance to apply its technology to treat knee, elbow and wrist injuries.

Previously, MedShape raised an undisclosed financial round from Arlington, Va.-based In-Q-Tel, a venture capital firm that supports the Central Intelligence Agency.

MedShape is in a market sweet spot. As the millions of fiercely independent baby boomers age, they will be voracious consumers of medical device implants in their struggle to maintain their hyperkinetic lifestyles.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES